Retriever Medical Receives Another U.S. patent for its Revolutionary Thrombectomy Systems
Innovative ClotHound System showcasing advanced catheter technology for mechanical thrombectomy and aspiration procedures.
Retriever Medical secures additional U.S. patent for its cutting-edge Thrombectomy Systems, reinforcing its position as a leader in medical innovation.
U.S. Pat. No. 11,957,367 underscores Retriever Medical's commitment to advancing patient care through innovative surgical solutions. As Ben Bobo, CEO of Retriever Medical, states, "This patent is a pivotal milestone for us, providing robust protection for our transformative thrombectomy system. It reaffirms our dedication to pushing the boundaries of interventional medicine and improving patient outcomes."
Retriever Medical's thrombectomy systems are meticulously engineered to effectively remove the entire spectrum of thrombus, encompassing acute, sub-acute, and chronic conditions, with unparalleled precision and efficacy. The patented technology enables mechanical expansion and contraction of expandable elements through a unique handle interface, offering unparalleled control and maneuverability during procedures.
The issuance of U.S. Pat. No. 11,957,367 further enhances Retriever Medical's robust intellectual property portfolio covering its thrombectomy systems, which now comprises ten (10) issued U.S. and two (2) international patents (totaling 132 issued patent claims), and over twenty (20) pending U.S. and foreign patent applications. Retriever Medical remains steadfast in its commitment to innovation and excellence, steadfastly pioneering advancements in healthcare.
For more information about Retriever Medical and its groundbreaking thrombectomy systems, please visit www.rtvmed.com.
About Retriever Medical: Retriever Medical, Inc. is dedicated to transforming interventional medicine by developing innovative surgical solutions, including the revolutionary ClotHound™ ACE thrombectomy systems. With a strong commitment to innovation and patient care, Retriever Medical remains at the forefront of advancing healthcare.
Investor Contact: Ben Bobo Phone: 714.654.2367 Email: bbobo@rtvmed.com
Safe Harbor Statement: This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are
based on current information and belief and are not guarantees of future performance. Actual results may differ materially from those indicated by forward-looking statements due to various risks and uncertainties. For more information on the risks and uncertainties associated with Retriever Medical's business, please refer to the Company's periodic Securities and Exchange Commission filings.
Retriever Medical and the Retriever Medical logo, ClotHound, ClotHound Blue, ClotHound Gold, ClotHound ACE, Clear ACE, ACE, VORS, and Blood Genie are trademarks of Retriever Medical. DogCurve, DogLeg, and DogTail are registered trademarks.
Ben Bobo
Retriever Medical, Inc.
+1 7146542367
email us here
Visit us on social media:
Twitter
LinkedIn
EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.
